Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (211-220 of 244) with videos related to

Pageof 25
Sort By:
Pancreas|September 26, 2003
Docetaxel and radiotherapy and pancreatic cancerF Viret, M Ychou, A Gonçalves, et al.
Breast Cancer Research and Treatment|August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapyP Viens, J Jacquemier, V J Bardou, et al.
Bone Marrow Transplantation|March 9, 2004
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatmentF Bertucci, C Tarpin, E Charafe-Jauffret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patientsP Viens, C Chabannon, P Pouillard, et al.
Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.
Bone Marrow Transplantation|November 20, 2003
Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapyF Viret, C Chabannon, D Sainty, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experienceJ Bonneterre, M Spielman, J P Guastalla, et al.
Bulletin of the World Health Organization|March 13, 2001
Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalisJ Pépin, F Sobéla, S Deslandes, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Pageof 25

Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
Pancreas|September 26, 2003
Docetaxel and radiotherapy and pancreatic cancerF Viret, M Ychou, A Gonçalves, et al.
Breast Cancer Research and Treatment|August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapyP Viens, J Jacquemier, V J Bardou, et al.
Bone Marrow Transplantation|March 9, 2004
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatmentF Bertucci, C Tarpin, E Charafe-Jauffret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patientsP Viens, C Chabannon, P Pouillard, et al.
Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.
Bone Marrow Transplantation|November 20, 2003
Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapyF Viret, C Chabannon, D Sainty, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experienceJ Bonneterre, M Spielman, J P Guastalla, et al.
Bulletin of the World Health Organization|March 13, 2001
Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalisJ Pépin, F Sobéla, S Deslandes, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Pageof 25